Literature DB >> 26185898

Minimally invasive resection and vertebroplasty for an osteolytic C-1 metastasis of malignant meningioma: case report.

Jan-Helge Klingler1, Marie Therese Krüger1, Evangelos Kogias1, Stefanie M Brendecke2, Ulrich Hubbe1, Christian Scheiwe1.   

Abstract

Malignant meningiomas are a rare but aggressive subset of intracranial meningiomas leading to a very limited life expectancy. The occurrence of spinal metastases in these tumors is an even rarer event. The described patient had an intracranial malignant meningioma and developed a symptomatic osteolytic contrast-enhancing lesion in the left C-1 lateral mass suspicious for metastasis. The authors performed a minimally invasive posterior resection of the lesion with vertebroplasty of C-1. Histopathology verified metastasis of the malignant meningioma. The surgical procedure resulted in prompt and permanent pain reduction until the patient died 18 months later. Given the very limited life expectancy in this case, the authors did not consider occipitocervical fusion because of their desire to preserve the range of motion of the head. Therefore, they suggest minimally invasive tumor resection and vertebroplasty in selected palliative tumor patients.

Entities:  

Keywords:  VAS = visual analog scale; WHO = World Health Organization; atlas; cement augmentation; cervical spine; malignant meningioma; metastasis; minimally invasive; oncology

Year:  2015        PMID: 26185898     DOI: 10.3171/2015.1.SPINE141041

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  2 in total

1.  WHO Grade I Meningioma Metastasis to the Lung 26 Years after Initial Surgery: A Case Report and Literature Review.

Authors:  Toshiyuki Enomoto; Mikiko Aoki; Yuki Kouzaki; Hiroshi Abe; Naoko Imamura; Akinori Iwasaki; Tooru Inoue; Kazuki Nabeshima
Journal:  NMC Case Rep J       Date:  2019-09-12

2.  Percutaneous Vertebroplasty for C1 Osteolytic Lesions via Lateral Approach Under Fluoroscopic Guidance.

Authors:  Yue Yang; Qinghua Tian; Dan Wang; Fei Yi; Hongmei Song; Wenbin Li; Chungen Wu
Journal:  J Pain Res       Date:  2021-07-13       Impact factor: 3.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.